Patent · US Active

Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer

US9062099B2 · kind B2 · utility

0Cited by
0References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 2010
Grant dateJun 23, 2015
Priority date
Expiry dateJan 5, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/4721
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to a method for the in vitro diagnosis of colorectal cancer by determining the presence of the Prodefensin-A6 tumour marker in a biological sample taken from a patient suspected of having colorectal cancer, it being possible for said method to be used both in early diagnosis, screening, therapeutic follow-up and prognosis, and in relapse diagnosis in relation to colorectal cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.